Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03711734 · ClinicalTrials.gov registry record · NA

Acupuncture ACL (Anterior Cruciate Ligament)

A NA study of Anesthesia and ACL Injury, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03711734: Completed NA study of Anesthesia and ACL Injury, sponsored by Hospital for Special Surgery, New York.

NCT03711734 is a NA study of Anesthesia and ACL Injury that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 40 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03711734, a NA study of Anesthesia and ACL Injury, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Acupuncture research in regards to PONV has been fairly well established, however, studies about perioperative pain control and acupuncture are a little more murky. In 2008, a meta analysis looked at randomized controlled studies and found that while acupuncture was shown to decrease pain, there were limitations including credible placebo or sham intervention, and thus, blinding. The main purpose of this feasibility trial is to determine whether or not adequate blinding is possible in the intraoperative setting with the patient sedated.

Primary Outcome

Patients' ability to determine whether or not they received acupuncture. The success of patient blinding in each group will be quantified using Bang Blinding Index (BI) which ranges from min = -1 to max = 1. Scores closest to 0 indicate a less likelihood that patients were able to guess which group they were randomized into. A score of 1 or -1 means that patients were able to guess which group they were in. This value is obtained by asking patients which group they believe they were randomly ass

Interventions

  • OTHER Acupuncture + Standard of Care

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-11-01
Est. Completion 2019-12-13
Phase NA

What the finished NCT03711734 record still lists

NCT03711734 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).

The record links to 5 conditions, with Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture + Standard of Care is the first listed.

NCT03711734 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03711734 about?

NCT03711734 is a clinical study titled "Acupuncture ACL (Anterior Cruciate Ligament)". Acupuncture research in regards to PONV has been fairly well established, however, studies about perioperative pain control and acupuncture are a little more murky. In 2008, a meta analysis looked at randomized controlled studies and found that while acupuncture was shown to decrease pain, there wer...

What is the current status of trial NCT03711734?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-11-01. Estimated completion is 2019-12-13.

What conditions does trial NCT03711734 study?

This clinical trial studies the following conditions: Anesthesia, ACL Injury, Anterior Cruciate Ligament Rupture, Anterior Cruciate Ligament Injury, ACL.

What interventions are being tested in trial NCT03711734?

The interventions under investigation include: Acupuncture + Standard of Care (OTHER).

Who is sponsoring clinical trial NCT03711734?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03711734 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03711734's enrollment target sits among peer trials

40 38th of 57 higher than 16 of 57 other Anesthesia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03711734, the US trial registry maintained by the National Library of Medicine. NCT03711734 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.